Glunz & Jensen H1 FY26 profit before tax falls 11.11% to DKK 5.6 million; revenue drops 10.07% to DKK 67 million
Reuters2026/08/19 11:43- Glunz & Jensen Holding reported H1 2026 revenue of DKK 67 million, down 10.07%.
- EBITDA fell 11.58% to DKK 8.4 million; profit before tax slipped 11.11% to DKK 5.6 million.
- EPS declined 11.11% to DKK 2.4; gross margin widened 0.9 percentage points to 27.2%.
- Customers delayed equipment pickups, postponing DKK 7.6 million of revenue; EBITDA and profit before tax hit by DKK 2.3 million.
- 2026 outlook unchanged; new broker appointed Aug. 1, 2026 for Selandia Park sale process, still expected to take 12-18 months.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
mRNA Cancer Vaccine Milestone! Moderna (MRNA.US) teams up with Merck (MRK.US) for successful melanoma trial, pre-market stock price surges 80%
Moderna Inc. and Merck & Co. announced that their personalized cancer vaccine has successfully reduced the risk of melanoma recurrence in a large-scale late-stage trial, marking a significant milestone for mRNA-based cancer therapies.
SP Group buys UK injection-moulding supplier OGM Moulding for GBP 18 million
Allot Chief Human Resources Officer Gili Groner sells 26,666 shares worth $209,543.88
Saba Capital Management disposes of $291,530 Pimco Dynamic Income Strategy Fund shares
